Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Net Debt Summary of Blau Farmacêutica S.A.

Blau Farmacêutica S.A.'s latest annual net debt in 2023 was 572.24 Million BRL , up 94.69% from previous year.
Blau Farmacêutica S.A.'s latest quarterly net debt in 2024 Q1 was 572.89 Million BRL , up 0.11% from previous quarter.
Blau Farmacêutica S.A. reported annual net debt of 293.92 Million BRL in 2022, down -8.3% from previous year.
Blau Farmacêutica S.A. reported annual net debt of 320.54 Million BRL in 2021, down -48.24% from previous year.
Blau Farmacêutica S.A. reported quarterly net debt of 533.9 Million BRL for 2024 Q2, down -6.81% from previous quarter.
Blau Farmacêutica S.A. reported quarterly net debt of 568.06 Million BRL for 2023 Q3, up 298.83% from previous quarter.

Annual Net Debt Chart of Blau Farmacêutica S.A. (2023 - 2015)

Historical Annual Net Debt of Blau Farmacêutica S.A. (2023 - 2015)

Year	Net Debt	Net Debt Growth
2023	572.24 Million BRL	94.69%
2022	293.92 Million BRL	-8.3%
2021	320.54 Million BRL	-48.24%
2020	619.32 Million BRL	127.27%
2019	272.5 Million BRL	27.31%
2018	214.05 Million BRL	125.9%
2017	94.75 Million BRL	-28.06%
2016	131.7 Million BRL	-7.43%
2015	142.27 Million BRL	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	572.89 Million BRL	0.11%
2024 Q2	533.9 Million BRL	-6.81%
2023 Q3	568.06 Million BRL	298.83%
2023 FY	572.24 Million BRL	94.69%
2023 Q1	289.86 Million BRL	-1.38%
2023 Q4	572.24 Million BRL	0.74%
2023 Q2	142.43 Million BRL	-50.86%
2022 Q2	299.67 Million BRL	146.1%
2022 FY	297.59 Million BRL	-8.3%
2022 Q4	293.92 Million BRL	-3.49%
2022 Q3	304.56 Million BRL	1.63%
2022 Q1	121.76 Million BRL	-62.01%
2021 Q4	320.54 Million BRL	-17.24%
2021 Q2	365.63 Million BRL	-53.44%
2021 Q1	785.32 Million BRL	26.8%
2021 FY	322.65 Million BRL	-48.24%
2021 Q3	387.32 Million BRL	5.93%
2020 FY	619.81 Million BRL	127.27%
2020 Q4	619.32 Million BRL	0.51%
2020 Q3	616.19 Million BRL	23.35%
2020 Q2	499.54 Million BRL	84.41%
2020 Q1	270.88 Million BRL	-0.6%
2019 Q1	209.29 Million BRL	-2.22%
2019 Q2	221.55 Million BRL	5.86%
2019 Q4	272.5 Million BRL	23.97%
2019 Q3	219.82 Million BRL	-0.78%
2019 FY	272.5 Million BRL	27.31%
2018 Q4	214.05 Million BRL	0.0%
2018 FY	214.05 Million BRL	125.9%
2017 FY	94.75 Million BRL	-28.06%
2016 FY	134.12 Million BRL	-7.43%
2015 FY	147.7 Million BRL	0.0%

Peer Net Debt Comparison of Blau Farmacêutica S.A.

Name	Net Debt	Net Debt Difference
Hypera S.A.	7.53 Billion BRL	92.401%